查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1854768

動物疼痛管理市場按動物類型、產品類型、給藥途徑、最終用戶和分銷管道分類－2025-2032年全球預測

Veterinary Pain Management Market by Animal Type, Product Type, Route Of Administration, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸醫疼痛管理市場將成長至 44.7 億美元，複合年成長率為 10.09%。

關鍵市場統計數據
基準年 2024 20.7億美元
預計年份：2025年 22.8億美元
預測年份 2032 44.7億美元
複合年成長率 (%) 10.09%

一個全面的框架，闡述了正在重新定義跨物種和跨醫療機構獸醫疼痛管理實踐的臨床和商業性動態。

隨著臨床醫生、生產商和經銷商積極應對不斷變化的動物健康重點、法律規範和客戶期望，獸醫疼痛管理領域正在迅速轉型。藥理學的進步、多模態鎮痛的興起以及對動物福利日益成長的關注，正在重塑伴侶動物、馬匹和農場動物的照護通訊協定。同時，技術賦能的診斷和數位療法也開始影響疼痛的評估和管理方式，為臨床工作流程的整合創造了新的機會。

決策者不僅需要了解產品層面的創新，還需要了解給藥方式、用藥偏好和終端使用者採購管道的變化。本報告整合了臨床、商業和分銷動態，全面展現了當前的實踐和新興的壓力。對治療模式、給藥途徑和醫務人員採納行為的重點分析，揭示了對產品開發、監管溝通和商業策略的實際啟示。轉型背景將臨床需求與市場機會連結起來，並為後續的策略考量奠定了基礎。

藥理學、給藥方法和分銷管道的創新如何重塑獸用鎮痛藥的臨床方案和商業策略

由於科學創新、監管調整和相關人員期望的轉變，獸醫鎮痛領域正在經歷變革。非類固醇消炎劑的進步、局部麻醉劑配方的改進以及人們對鴉片類藥物管理的重新關注，正在改變臨床治療流程。同時，給藥途徑的進步，例如長效注射劑和經皮製劑，正在擴大鎮痛藥的覆蓋範圍並提高其依從性，尤其是在門診病人和居家醫療環境中。

在商業方面，隨著數位藥局和直接面對消費者模式的日益普及，分銷管道日益碎片化，迫使製造商重新思考其通路策略和病患支援服務。獸醫醫院和診所正在發展成為更完善的醫療中心，需要全面的產品支援、培訓和循證通訊協定。這種多方力量的融合正在重塑競爭格局和市場開發方法，促進藥理學家、醫療器材動態和獸醫之間的多學科合作，共同開發符合日益提高的療效、安全性和動物福利標準的解決方案。

評估美國在2025年宣布或實施的關稅對供應鏈、採購和臨床連續性的連鎖影響

美國2025年可能加徵關稅的前景將對獸醫疼痛管理領域的相關人員產生多方面的影響，包括供應鏈、採購成本和策略採購決策。依賴全球生產網路採購活性原料藥、輔料和成品製​​劑的製造商可能面臨更高的到岸成本和前置作業時間延長，促使他們尋求供應商多元化或重新評估近岸外包方案。對於契約製造製造商和經銷商而言，進口關稅的增加可能會壓縮利潤空間，促使他們精簡營運並與通路合作夥伴重新談判條款。

診所和醫院在採購專有或特殊配方藥物時，可能會遇到採購摩擦，因為經銷商將增加的成本轉嫁給客戶或調整庫存政策。為此，採購方可能會尋求長期採購協議、尋找替代學名藥或增加國內庫存以緩解短期波動。此外，監管、海關和文件方面的負擔可能會增加行政成本並延遲產品上市。這些動態共同凸顯了情境規劃、供應鏈分析以及與物流合作夥伴積極溝通的重要性，以確保醫療服務的連續性和關鍵疼痛治療藥物的可近性。

以細分市場主導的策略要務闡明了物種、治療層級、給藥途徑、最終用戶和分銷管道的選擇將如何影響臨床應用和商業性定位。

透過市場區隔獲得的洞察揭示了不同動物種類、產品類別、給藥途徑、最終用戶和通路在臨床和商業性行為方面的差異。按動物類型（貓、狗、馬和牲畜）分析，鎮痛藥物類別的使用模式因物種特異性的動態、給藥複雜性和客戶期望而異，從而推動了差異化的產品開發和標籤策略。在產品類型內部，局部麻醉劑、非類固醇消炎劑和鴉片類藥物之間的差異揭示了監管審查、管理考慮和臨床適應症的差異。在非類固醇消炎劑類別中，卡洛芬、氟尼辛、美洛昔康和羅貝考昔等藥物之間又存在進一步的區分，每種藥物都具有獨特的安全性特徵和獸醫處方偏好。

依給藥途徑（注射、口服、局部和經皮）進行細分，突顯了以使用者為中心的權衡因素，例如起效時間、持續時間和給藥便利性。注射劑又細分為肌肉注射、靜脈注射和皮下注射，以適應不同的治療環境和患者接受度；局部劑型包括凝膠、貼片和噴霧劑，可支持居家給藥和局部治療。終端用戶細分體現了線上藥局、研究機構、零售藥局、獸醫診所和動物醫院等不同機構的採購週期、合規要求和服務期望如何影響商業性合作。最後，按分銷管道（直銷、醫院藥房、線上藥房和零售藥房）進行細分，闡明了上市途徑的選擇如何影響定價、促銷和產品支援方面的投入，凸顯了針對不同管道製定價值提案和夥伴關係模式的必要性。

美洲、歐洲、中東和非洲以及亞太地區的監管、臨床和分銷方面的細微差別會影響市場准入和商業化策略。

美洲、歐洲、中東和非洲以及亞太地區的市場動態差異顯著，不同的法律規範、臨床實務模式和供應鏈結構都會影響產品的存取和商業化。在美洲，診所間更緊密的整合以及數位化採購的普及提高了效率，同時，消費者對配套服務和培訓支援的期望也在不斷提高。此外，監管路徑往往更傾向於已建立的藥物安全檢測體系，這體現在上市後監測策略中。

在歐洲、中東和非洲，不同的法規和報銷模式要求採取量身定做的監管和市場策略，同時，對獸醫教育和動物福利標準的持續投入也推動了對循證鎮痛方案的需求。亞太地區基礎設施快速發展，獸醫服務網路不斷擴展，但各地生產能力參差不齊，這促使企業與區域經銷商建立合作關係，並投資於紮根於當地的供應鏈。要成功利用這些區域差異，需要採取適應性強的監管策略、符合當地文化的行銷策略以及能夠協調全球產品標準與當地市場實際情況的分銷模式。

醫藥和動物用藥品之間的競爭動態和策略行動正在塑造以證據、服務和管道為中心的差異化。

動物疼痛管理領域的競爭格局呈現出多元化的特點，既有成熟的製藥企業，也有專注於動物用藥品的公司，還有不斷研發新配方和給藥系統的創新企業。領導企業透過優先提供可靠的臨床證據、針對獸醫專業人員進行有針對性的教育和推廣活動，以及加大對產品安全監測的投入，來打造差異化優勢。為了尋求在配方科學、分銷網路或當地監管專業知識方面的互補能力，戰略聯盟和許可協議十分常見。

產品差異化越來越依賴良好的耐受性、簡化的給藥方案或在實際應用中展現出的顯著優勢，而提供培訓模組、劑量計算器和客戶教育材料等綜合支援服務的公司則獲得了更深入的臨床應用。競爭定位也體現在通路選擇：有些公司強調與醫院藥局和獸醫診所的合作，而有些公司則專注於零售和線上藥局的銷售，以吸引注重便利性的終端用戶。這些發展趨勢為尋求開拓細分市場的專業參與企業創造了機會，而大型公司則透過豐富的產品組合和深入的服務來鞏固其市場地位。

製造商和經銷商可以採取切實可行的策略步驟，以增強供應韌性、促進臨床醫生採用產品並最佳化管道特定的商業性策略。

產業領導者應採取一系列切實可行的措施，以增強韌性，加速差異化治療方法的推廣應用，並使商業模式與不斷發展的臨床實踐相適應。首先，製造商和經銷商應實施全面的供應鏈映射和雙源籌資策略，以降低關稅波動和原物料短缺帶來的風險。其次，投資獸醫專業人員和客戶的多藥鎮痛教育，有助於循證處方，並透過可驗證的療效和更高的用藥依從性來提升產品價值。

第三，優先開發以使用者為中心的劑型，例如長效注射劑和經皮貼劑，可以解決用藥依從性問題，並改善不同動物物種的患者福利。第四，企業應根據獸醫診所、醫院、零售藥局和線上平台的具體需求，量身訂做通路策略，提供差異化的商業性獎勵和服務組合。最後，積極與監管機構溝通並加強上市後監測，可以降低安全隱患，並促進產品更快被市場接受。總而言之，這些措施使企業能夠在應對競爭壓力的同時，為臨床醫生和動物飼主帶來切實可見的益處。

透過嚴謹的混合方法研究途徑，結合專家訪談、臨床文獻綜合和基於情境的供應鏈分析，獲得可操作的洞見。

本分析的調查方法結合了定性專家訪談、系統文獻綜述以及監管指南和臨床實踐資源的綜合分析，以確保各相關人員的觀點平衡。主要資訊來源包括與執業獸醫、藥理學家、監管專家和分銷主管進行的結構化諮詢，以了解實際決策因素、治療偏好和採購慣例。次要資訊來源則依賴同儕審查的臨床研究、藥理學教科書和官方監管文件，以檢驗主要鎮痛藥及其給藥平台的安全性、劑量注意事項和標籤說明。

此分析方法結合了跨細分市場映射和基於情境的供應鏈壓力測試，以評估脆弱性和應對方案。透過對一手訪談和二手資料進行三角驗證，減少了偏差，提高了主題結論的穩健性。必要時，也進行了敏感度分析，以檢驗關稅引發的成本壓力、通路轉移以及新管理實務的採用所帶來的影響。這種混合調查方法框架既能提供可操作的洞見，又能保持方法論的透明度和可重複性。

整合策略重點，使臨床創新、監管預期和商業性韌性保持一致，從而改善獸醫疼痛護理和組織績效。

總之，獸醫疼痛管理領域正處於曲折點，臨床創新、不斷變化的經銷管道以及宏觀經濟壓力正在交匯融合，重新定義機會與風險。積極整合供應鏈韌性、投資於臨床醫生教育、並根據物種和環境特定需求調整產品和管道策略的利益相關者，將更有利於改善患者預後並獲得商業性優勢。監管相關人員、給藥途徑偏好和終端用戶採購行為之間的相互作用，要求制定一項將臨床證據與切實可行的市場推廣策略相結合的協作策略。

隨著市場不斷發展，各機構應優先考慮適應性規劃、合作夥伴關係以及對上市後證據的持續投入，以支持產品的長期認可和信任。聚焦這些策略支柱將使公司和護理機構能夠應對短期挑戰，同時朝著提高伴侶動物、馬匹和牲畜疼痛管理標準的目標邁進。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 在小動物臨床實務中推廣整合非類固醇抗發炎藥、鴉片類藥物和局部麻醉劑的多模態鎮痛通訊協定
  • 使用長效注射止痛藥進行馬術後疼痛管理
  • 利用穿戴式感測器技術客觀監測寵物疼痛和活動
  • 遠端醫療和遠距診療平台在伴侶動物慢性疼痛評估的普及
  • 將富血小板血漿和幹細胞等再生療法應用於關節疼痛治療
  • 開發包括經皮神經電刺激（TENS）和針灸在內的非鴉片類神經調節技術用於貓的慢性疼痛管理。
  • 針對犬貓發炎疼痛途徑的新興物種特異性單株抗體
  • 在獸醫患者中，人們越來越關注透過基因生物標記和精準給藥進行個人化疼痛管理。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依動物類型分類的動物疼痛管理市場

  • 貓
  • 狗
  • 馬
  • 家畜

9. 依產品類型分類的動物疼痛管理市場

  • 局部麻醉劑
  • 非類固醇消炎劑
    • 卡洛芬
    • 氟尼辛
    • 美洛昔康
    • 羅貝那昔布
  • 鴉片類藥物

第10章 依給藥途徑分類的動物疼痛管理市場

  • 注射
    • 肌肉內注射
    • 靜脈
    • 皮下
  • 口服
  • 話題
    • 凝膠
    • 修補
    • 噴
  • 經皮

第11章：按最終用戶分類的動物疼痛管理市場

  • 網路藥房
  • 研究機構
  • 零售藥房
  • 獸醫診所
  • 獸醫診所

第12章：按通路分類的動物疼痛管理市場

  • 直銷
  • 醫院藥房
  • 網路藥房
  • 零售藥房

第13章 動物疼痛管理市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：依組別分類的動物疼痛管理市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國動物疼痛管理市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Zoetis Inc.
    • Elanco Animal Health Incorporated
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Dechra Pharmaceuticals PLC
    • Ceva Sante Animale SA
    • Vetoquinol SA
    • Norbrook Laboratories Limited
    • Virbac SA
    • Phibro Animal Health Corporation
Product Code: MRR-957C47F93EAD

The Veterinary Pain Management Market is projected to grow by USD 4.47 billion at a CAGR of 10.09% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.07 billion
Estimated Year [2025] USD 2.28 billion
Forecast Year [2032] USD 4.47 billion
CAGR (%) 10.09%

Comprehensive framing of clinical and commercial dynamics redefining veterinary pain management practices across species and care settings

The veterinary pain management landscape is undergoing rapid transformation as clinicians, manufacturers, and distributors respond to evolving animal health priorities, regulatory frameworks, and client expectations. Advances in pharmacology, a shift toward multimodal analgesia, and heightened attention to animal welfare are reshaping protocols across companion, equine, and production animal practice. At the same time, technology-enabled diagnostics and digital therapeutics are beginning to influence how pain is assessed and managed, creating new opportunities for integration across clinical workflows.

Decision-makers must understand not only product-level innovations but also changes in delivery modalities, administration preferences, and end-user procurement pathways. This report synthesizes clinical, commercial, and distributional dynamics to provide a consolidated view of current practice and emergent pressures. By focusing on treatment modalities, administration routes, and practitioner adoption behaviors, the analysis highlights actionable implications for product development, regulatory engagement, and commercial strategy. Transitional context links clinical need to market opportunity and frames the strategic considerations that follow.

How innovations in pharmacology, delivery methods, and distribution channels are jointly reshaping clinical protocols and commercial strategies in veterinary analgesia

The landscape for veterinary analgesia is experiencing transformative shifts driven by scientific innovation, regulatory recalibration, and changing stakeholder expectations. Advances in nonsteroidal anti-inflammatory agents, refinement of local anesthetic formulations, and renewed attention to opioid stewardship are altering therapeutic algorithms in clinical practice. Concurrently, progress in routes of administration-such as long-acting injectables and transdermal delivery systems-enables extended analgesic coverage and improved compliance, particularly in outpatient or home-care environments.

On the commercial side, distribution channels are fragmenting as digital pharmacies and direct-to-consumer models gain traction, prompting manufacturers to reassess channel strategies and patient support services. Veterinary clinics and hospitals are evolving into more sophisticated care hubs that demand integrated product support, training, and evidence-based protocols. These converging forces are incentivizing cross-disciplinary collaborations among pharmacologists, device developers, and veterinary practitioners to co-develop solutions that meet rising standards for efficacy, safety, and animal welfare, thereby reshaping competitive dynamics and go-to-market approaches.

Evaluating the cascading supply chain, procurement, and clinical continuity effects stemming from United States tariff measures announced or implemented in 2025

The prospect of tariffs introduced by the United States in 2025 carries multifaceted implications for veterinary pain management stakeholders, affecting supply chains, procurement costs, and strategic sourcing decisions. Manufacturers that rely on global manufacturing networks for active pharmaceutical ingredients, excipients, or finished formulations may face higher landed costs and disrupted lead times, prompting a reassessment of supplier diversification and nearshoring options. For contract manufacturers and distributors, greater import duties can compress margins and incentivize operational efficiencies or renegotiated commercial terms with channel partners.

Clinics and hospitals that procure proprietary or specialized formulations may experience procurement friction as distributors pass through cost increases or adjust inventory policies. In response, buyers could pursue longer-term purchase agreements, seek alternative generics, or increase onshore stockpiling to mitigate short-term volatility. Additionally, regulatory compliance, customs processing, and documentation burdens could introduce administrative overheads that slow product introductions. Collectively, these dynamics underscore the importance of scenario planning, supply chain mapping, and proactive engagement with logistics partners to preserve continuity of care and maintain access to critical analgesic therapies.

Segment-driven strategic imperatives showing how species, therapeutic class, administration route, end user, and distribution choices shape clinical adoption and commercial positioning

Insights derived from segmentation illuminate distinct clinical and commercial behaviors across animal type, product class, administration route, end user, and distribution pathways. When analyzed by animal type-cats, dogs, equine, and livestock-adoption patterns for analgesic classes diverge due to species-specific pharmacodynamics, dosing complexity, and client expectations, driving differentiated product development and labeling strategies. Within product type segmentation, distinctions among local anesthetics, nonsteroidal anti-inflammatory drugs, and opioids reveal varying regulatory scrutiny, stewardship considerations, and clinical indications; the nonsteroidal anti-inflammatory category further differentiates around agents such as carprofen, flunixin, meloxicam, and robenacoxib, each associated with unique safety profiles and veterinary prescribing preferences.

Route of administration segmentation-injectable, oral, topical, and transdermal-highlights user-centric trade-offs between onset, duration, and ease of administration; injectable options subdivide into intramuscular, intravenous, and subcutaneous approaches tailored to care setting and patient tolerance, while topical applications encompass gels, patches, and sprays that support at-home management or localized therapy. End user segmentation captures how online pharmacies, research institutes, retail pharmacies, veterinary clinics, and veterinary hospitals impose different procurement cycles, compliance requirements, and service expectations that shape commercial engagement. Finally, distribution channel segmentation-direct distribution, hospital pharmacies, online pharmacies, and retail pharmacies-illustrates how route-to-market choices influence pricing, promotional focus, and product support investments, underscoring the need for channel-specific value propositions and partnership models.

Regional regulatory, clinical practice, and distribution nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence access and commercialization strategies

Regional dynamics vary substantially across the Americas, Europe Middle East & Africa, and Asia-Pacific, each presenting distinct regulatory frameworks, clinical practice patterns, and supply chain architectures that influence product access and commercialization. In the Americas, practice consolidation among clinics and increasing use of digital procurement create efficiencies but also raise expectations for bundled service offerings and training support; regulatory pathways tend to favor well-established pharmacovigilance systems, which informs post-market surveillance strategies.

Across Europe, the Middle East & Africa, regulatory heterogeneity and divergent reimbursement models require tailored regulatory and market access approaches, while growing investments in veterinary education and welfare standards are driving demand for evidence-based analgesic protocols. The Asia-Pacific region exhibits rapid infrastructure development, expanding veterinary service networks, and variable local manufacturing capacity, which together incentivize partnerships with regional distributors and investments in localized supply chain resilience. Navigating these regional nuances calls for adaptive regulatory strategy, culturally attuned marketing, and distribution models that reconcile global product standards with local market realities.

Competitive dynamics and strategic behaviours among pharmaceutical and specialty animal health companies shaping differentiation through evidence, services, and channel focus

The competitive landscape in veterinary pain management is characterized by a mix of established pharmaceutical manufacturers, specialty animal health companies, and agile innovators developing new formulations and delivery systems. Leading organizations prioritize robust clinical evidence generation, targeted educational outreach to veterinary professionals, and investments in product safety monitoring to differentiate their offerings. Strategic collaborations and licensing agreements are common as companies seek complementary capabilities in formulation science, distribution networks, or regional regulatory expertise.

Product differentiation increasingly depends on demonstrating superior tolerability, simplified dosing regimens, or clear advantages in real-world settings, while companies that offer integrated support services-such as training modules, dosing calculators, and client education materials-achieve deeper clinical engagement. Competitive positioning also reflects decisions about channel focus; some companies emphasize partnerships with hospital pharmacies and veterinary hospitals for high-touch engagement, whereas others optimize for retail and online pharmacy distribution to capture convenience-driven end users. These dynamics create openings for specialized entrants to capture niche segments while larger firms consolidate presence through portfolio breadth and service depth.

Actionable strategic measures for manufacturers and distributors to fortify supply resilience, accelerate clinician adoption, and optimize channel-specific commercial approaches

Industry leaders should pursue a set of pragmatic actions that strengthen resilience, accelerate adoption of differentiated therapies, and align commercial models with evolving clinical practice. First, manufacturers and distributors need to execute comprehensive supply chain mapping and dual-sourcing strategies to reduce exposure to tariff-driven disruptions and raw material shortages. Second, investing in multimodal analgesia education for veterinary professionals and clients will support evidence-based prescribing and enhance product value through demonstrable outcomes and adherence improvements.

Third, prioritizing development of user-centric administration formats-such as long-acting injectables or transdermal patches-can address adherence challenges and improve patient welfare across species. Fourth, companies must tailor channel strategies to meet the distinct needs of veterinary clinics, hospitals, retail pharmacies, and online platforms, offering differentiated commercial incentives and service bundles. Finally, proactive regulatory engagement and robust post-market surveillance will mitigate safety concerns and support faster market acceptance; collectively, these measures will enable organizations to respond to competitive pressures while delivering measurable benefits to clinicians and animal owners.

Rigorous mixed-method research approach combining expert interviews, clinical literature synthesis, and scenario-based supply chain analysis to produce actionable insights

The research methodology underpinning this analysis integrates qualitative expert interviews, systematic literature review, and synthesis of regulatory guidance and clinical practice resources to ensure balanced perspectives across stakeholders. Primary inputs included structured consultations with practicing veterinarians, pharmacologists, regulatory specialists, and distribution executives to capture real-world decision drivers, therapeutic preferences, and procurement practices. Secondary inputs relied on peer-reviewed clinical studies, pharmacology texts, and public regulatory documentation to validate safety profiles, administration considerations, and labeling implications for key analgesic agents and delivery platforms.

Analytical approaches combined cross-segmentation mapping with scenario-based supply chain stress testing to evaluate vulnerabilities and response options. Triangulation between primary interviews and secondary sources was applied to reduce bias and enhance the robustness of thematic conclusions. Where appropriate, sensitivity analyses were used to examine the implications of tariff-induced cost pressures, channel shifts, and adoption of new administration modalities. This mixed-method framework supports actionable insights while preserving methodological transparency and reproducibility.

Synthesis of strategic priorities that reconcile clinical innovation, regulatory expectations, and commercial resilience to advance veterinary pain care and organizational performance

In conclusion, the veterinary pain management sector is at an inflection point where clinical innovation, distribution evolution, and macroeconomic pressures converge to redefine opportunity and risk. Stakeholders that proactively integrate supply chain resilience, invest in clinician education, and tailor product and channel strategies to species- and setting-specific needs will be best positioned to deliver improved patient outcomes and secure commercial advantage. The interplay between regulatory expectations, administration route preferences, and end-user procurement behaviors demands coordinated strategies that align clinical evidence with pragmatic go-to-market tactics.

As markets continue to evolve, organizations should prioritize adaptive planning, collaborative partnerships, and sustained investment in post-market evidence generation to support long-term acceptance and trust. By focusing on these strategic pillars, companies and care providers can navigate near-term disruptions while advancing toward higher standards of pain management across companion, equine, and livestock populations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expansion of multimodal analgesia protocols integrating NSAIDs, opioids, and local anesthetics in small animal practice
  • 5.2. Adoption of long acting injectable analgesic formulations for equine postoperative pain management
  • 5.3. Implementation of wearable sensor technology for objective pain and mobility monitoring in pets
  • 5.4. Surge in telemedicine and remote consultation platforms for chronic pain assessment in companion animals
  • 5.5. Integration of regenerative therapies such as platelet rich plasma and stem cells for joint pain
  • 5.6. Development of non opioid neuromodulation techniques including TENS and acupuncture for feline chronic pain management
  • 5.7. Emergence of species specific monoclonal antibodies targeting inflammatory pain pathways in dogs and cats
  • 5.8. Increasing focus on personalized pain management driven by genomic biomarkers and precision dosing in veterinary patients

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Pain Management Market, by Animal Type

  • 8.1. Cats
  • 8.2. Dogs
  • 8.3. Equine
  • 8.4. Livestock

9. Veterinary Pain Management Market, by Product Type

  • 9.1. Local Anesthetics
  • 9.2. Nonsteroidal Anti-Inflammatory Drugs
    • 9.2.1. Carprofen
    • 9.2.2. Flunixin
    • 9.2.3. Meloxicam
    • 9.2.4. Robenacoxib
  • 9.3. Opioids

10. Veterinary Pain Management Market, by Route Of Administration

  • 10.1. Injectable
    • 10.1.1. Intramuscular
    • 10.1.2. Intravenous
    • 10.1.3. Subcutaneous
  • 10.2. Oral
  • 10.3. Topical
    • 10.3.1. Gels
    • 10.3.2. Patches
    • 10.3.3. Sprays
  • 10.4. Transdermal

11. Veterinary Pain Management Market, by End User

  • 11.1. Online Pharmacies
  • 11.2. Research Institutes
  • 11.3. Retail Pharmacies
  • 11.4. Veterinary Clinics
  • 11.5. Veterinary Hospitals

12. Veterinary Pain Management Market, by Distribution Channel

  • 12.1. Direct Distribution
  • 12.2. Hospital Pharmacies
  • 12.3. Online Pharmacies
  • 12.4. Retail Pharmacies

13. Veterinary Pain Management Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Veterinary Pain Management Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Veterinary Pain Management Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Zoetis Inc.
    • 16.3.2. Elanco Animal Health Incorporated
    • 16.3.3. Merck & Co., Inc.
    • 16.3.4. Boehringer Ingelheim International GmbH
    • 16.3.5. Dechra Pharmaceuticals PLC
    • 16.3.6. Ceva Sante Animale S.A.
    • 16.3.7. Vetoquinol S.A.
    • 16.3.8. Norbrook Laboratories Limited
    • 16.3.9. Virbac S.A.
    • 16.3.10. Phibro Animal Health Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. VETERINARY PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. VETERINARY PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VETERINARY PAIN MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY EQUINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY EQUINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY EQUINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY EQUINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY EQUINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY EQUINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LIVESTOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CARPROFEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CARPROFEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CARPROFEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CARPROFEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CARPROFEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CARPROFEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY FLUNIXIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY FLUNIXIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY FLUNIXIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY FLUNIXIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY FLUNIXIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY FLUNIXIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY MELOXICAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY MELOXICAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY MELOXICAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY MELOXICAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY MELOXICAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY MELOXICAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROBENACOXIB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROBENACOXIB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROBENACOXIB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROBENACOXIB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROBENACOXIB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROBENACOXIB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PATCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PATCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PATCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PATCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PATCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SPRAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SPRAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SPRAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SPRAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SPRAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SPRAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DIRECT DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DIRECT DISTRIBUTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DIRECT DISTRIBUTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DIRECT DISTRIBUTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DIRECT DISTRIBUTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DIRECT DISTRIBUTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET S